Company: TELO
Filing Date: 2025-11-20
Form Type: PREM14A
Source: 0001493152-25-024463
Chunk: 125

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: PREM14A
Chunk 125
---
ive-Based Compensation (as determined by our Board of Directors or Compensation Committee) received by any Covered Officer during the three completed fiscal years immediately preceding the date on which we are required to prepare such accounting restatement.

The foregoing description of our Compensation Recovery Policy does not purport to be complete and is qualified in its entirety by the terms and conditions of such policy, a copy of which is filed as an exhibit to this Report and is incorporated herein by reference.

Vote Required

The affirmative vote of a majority of the voting power present or represented by proxy is required to approve the Plan Amendment Proposal. Abstentions represent the voting power present under the Company’s amended and restated bylaws, and accordingly will have the same effect as a vote “AGAINST” the outcome of this Proposal 4.

<div align='center'>THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THE PLAN AMENDMENTS.</div>

| 73 |

<div align='center'>PROPOSAL NO. 5:

APPROVAL OF AMENDMENT TO BYLAWS TO REDUCE QUORUM</div>

Under Section 2.9 of the current Amendment and Restated Bylaws of TELO (the “Bylaws”), for a meeting of shareholder of TELO, a majority of the votes entitled to be cast on the matter shall constitute a quorum of the voting group for action on that matter. In order to facilitate the ease of achieving a quorum at future shareholder meetings, Annual Meeting, stockholders are being asked to approve an amendment to the Bylaws to reduce the amount required for a quorum for an action by the TELO shareholders adopted in a meeting to one third.

Vote Required

The affirmative vote of a majority of the voting power present or represented by proxy is required to approve the Bylaws Amendment Proposal. Abstentions represent the voting power present under the Company’s amended and restated bylaws, and accordingly will have the same effect as a vote “AGAINST” the outcome of this Proposal 5.

<div align='center'>PROPOSAL NO. 6:

APPROVAL OF OPTION GRANTS TO NON-EXECUTIVE DIRECTORS</div>

We believe that our compensation proposal for non-executive directors will be effective in incentivizing achievement of key strategic objectives (operational and market based) which will result in long-term sustainable shareholder value, while keeping our director compensation packages competitive with the practices applied by other companies in our industry with a comparable market size. We are proposing the